Company
Management
Christophe Thurieau
Chief Executive Officer
Executive Director of Research Institute and Global Head of External Research at Servier- In his rol… Read moree at Servier , Dr Christophe Thurieau is leading Servier’s Research centers and as head of external Research he is responsible for World Wide Research hubs to establish external strategic partnerships in R&D. Before joining Servier in April 2017 Dr Christophe Thurieau worked at Ipsen from 1996 to 2017. After different increasing roles and responsibilities within Research and Development at Ipsen, he was since 2009 President Ipsen Innovation and Senior Vice –President Global Scientific Affairs at Ipsen. He has authored more than 30 original research articles in international peer-reviewed scientific journal and holds 25 patents. Dr Christophe Thurieau obtained pre and post-doctoral training at Harvard medical school, Boston (U.S.) and received his Ph.D. in biochemistry from University Pierre and Marie Curie, Paris VI in 1988.
Rikke Bolding Jensen, M.Sc, Ph.d,
SVP, CMC
Rikke Bolding Jensen, M.Sc, Ph.d, is a Danish national, born in 1969. She joined Symphogen in 2014.… Read more
Before joining Symphogen, Rikke Bolding Jensen served development and CMC project management positions in Nycomed/Takeda and Maxygen.
Before joining Symphogen, Rikke Bolding Jensen served development and CMC project management positions in Nycomed/Takeda and Maxygen.
Karin Garre, MD
General Manager
Karin Garre, MD, is a Danish-national, born in 1957. She joined Symphogen in 2018 to take the lead f… Read moreor strategic portfolio management and was since 2019 appointed Chief Operating Officer.
Before joining Symphogen, Karin Garre has held managerial and executive leadership positions in the Danish health care sector and international pharmaceutical pharma and biotech industries such as Novo Nordisk, Nycomed, Genmab and NeuroSearch.
Before joining Symphogen, Karin Garre has held managerial and executive leadership positions in the Danish health care sector and international pharmaceutical pharma and biotech industries such as Novo Nordisk, Nycomed, Genmab and NeuroSearch.
Lisbet Løschenkohl
SVP, People & Facility
Lisbet Løschenkohl is a Danish national, born in 1967. She joined Symphogen in 2008 as Head of HR.<… Read morebr />
Before joining Symphogen, Lisbet Løschenkohl headed the HR and Facility function in Rheosciene and Center for Clinical and Basic Research.
Mikkel Wandahl Pedersen, Ph.d
SVP and Acting Chief Scientific Officer
Mikkel Wandahl Pedersen, PhD, is a Danish national, born in 1973. He joined Symphogen in 2006 as sci… Read moreentist, was appointed Director of Cancer Biology and Immunology in 2012 and Vice President of Antibody Discovery and Research in 2018.
Before joining Symphogen, Mikkel W. Pedersen was leader of the receptor tyrosine kinase group at Department of Radiation Biology at Copenhagen University Hospital. Mikkel W. Pedersen has authored over 40 peer-reviewed publications
Before joining Symphogen, Mikkel W. Pedersen was leader of the receptor tyrosine kinase group at Department of Radiation Biology at Copenhagen University Hospital. Mikkel W. Pedersen has authored over 40 peer-reviewed publications